Antidiabetic effect of Cephalotaxus sinensis leaf extract (STP) in STZ-induced diabetic rats by its antioxidant activity

HealthMED

Volumn 4, Issue 2, 2010, Pages 316-322

  Wu, Chong Ming ^a   Lao, Xin Yuan ^a   Li, Wei ^a   Li, Yan ^a   Deng, Yu Lin ^a  

^a BEIJING INSTITUTE OF TECHNOLOGY   (China)

Author keywords

Antidiabetic; Antioxidant; Blood glucose; Cephalotaxus sinensis; Insulin; MDA; SOD

Indexed keywords

EID: 77954279318     PISSN: 18402291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Li, W., Dai, R.J., Yu, Y.H., Li, L., Wu, C.M., Luan, W.W., Meng, W.W., Zhang, X.S., Deng, Y.L. Antihyperglycemic Effect of Cephalotaxus sinensis Leaves and GLUT-4 Translocation Facilitating Activity of Its Flavonoid Constituents Biol. Pharm. Bull. 2007; 30, 1123-1129.
2. International Diabetes Federation. IDF - International Diabetes Federation - Prevalence. 2005. .
3. Reaven, G.M. Abnormal lipoprotein metabolism in non-insulin-dependent diabetes mellitus. Pathogenesis and treatment. Am. J. Med. 1987; 83, 31-40.
4. Woerle, H.J., Szoke, E., Meyer, C., Dostou, J.M., Wittlin, S.D., Gosmanov, N.R., Welle, S.L., Gerich, J.E. Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 2006; 290, 67-77.
5. Bhor, V.M., Sivakami, S. Regional variations in intestinal brush border membrane fluidity and function during diabetes and the role of oxidative stress and non-enzymatic glycation. Mol. Cell Biochem. 2003; 252, 125-132.
6. Bhor, V.M., Raghuram, N., Sivakami, S. Oxidative damage and altered antioxidant enzyme activities in the small intestine of streptozotocin-induced diabetic rats. Int. J. Biochem. Cell Biol. 2004; 36, 89-97.
7. Kanth, V.R., Reddy P.U.M., Raju, T.N. Attenuation of streptozotocin-induced oxidative stress in hepatic and intestinal tissues of wistar rat by methanolicgarlic extract. Acta Diabetol. 2008; 45, 243-251.
8. Pari L., Umamaheswari J. Antihyperglycaemic activity of Musa sapientum flowers: effect on lipid peroxidation in alloxan diabetic rats. Phytother. Res. 2000; 14, 1-3.
9. Kong, J.M., Goh, N-K., Chia, L-S., Chia, T-F. Recent advances in traditional plant drugs and orchids. Acta Pharmacol. Sin. 2003; 24, 7-21.
10. WHO Expert Committee. Diabetes Mellitus (Tech. Rep. Ser. 646), 2nd Rep, Geneva, World Health Organization. 1980.
11. Jouad, H., Haloui, M., Rhiouani, H., El, H.J., Eddouks, M. Ethnobotanical survey of medicinal plants used for the treatment of diabetes, cardiac and renal diseases in the north centre region of Morocco (Fez-Bouemane). J. Ethnopharmacol. 2000; 77, 175-182.
12. Dieye, A.M., Sarr, A., Diop S.N., Ndiaye, M., Sy, G.Y., Diarra, M., Rajraji, G.I., Ndiaye, S.A., Faye, B. Medicinal plants and the treatment of diabetes in Senegal: survey with patients. Fundam. Clin. Pharmacol. 2008; 22, 21-216.
13. Gondwe, M., Kamadyaapa, D.R., Tufts, M., Chuturgoon, A.A., Musabayane, C.T. Sclerocarya birrea [(A. Rich.) Hochst.] [Anacardiaceae] stembark ethanolic extract (SBE) modulates blood glucose, glomerular filtration rate (GFR) and mean arterial blood pressure (MAP) of STZ-induced diabetic rats. Phytomedicine 2008; 15, 699-709.
14. Kuo, Y.H., Hwang, S.Y., YangKuo, L.M., Lee, Y.L., Li, S.Y., Shen, Y.C. A novel cytotoxic C-methylated biflavone, taiwanhomoflavone-B from the twigs of Cephalotaxus wilsoniana. Chem. Pharm. Bull. 2002; 50, 1607-1608.
15. Politi, M., Braca, A., De Tommasi, N., Morelli, I., Manunta, A., Battinelli, L., Mazzanti, G. Antimicrobial diterpenes from the seeds of Cephalotaxus harringtonia var. drupacea. Planta Med. 2003; 69, 468-470.
16. Wang, L.W., Su, H.J., Yang, S.Z., Won, S.J., Lin, C.N. New Alkaloids and a Tetraflavonoid from Cephalotaxus wilsoniana. J. Nat. Prod. 2004; 67, 1182-1185.
17. Li W., Deng, Y.L., Dai, R.J., Yu, Y.H., Saeed, M.K., Li, L., Meng, W.W., Zhang, X.S. Chromatographic fingerprint analysis of Cephalotaxus sinensis from various sources by high-performance liquid chromatography- diodearray detection-electrospray ionization-tandem mass spectrometry. J. Pharmaceut. Biomed. 2007; 45, 38-46.
18. Editorial Board of Zhonghua Bencao. Zhonghua Bencao, vol. 2. Shanghai Scientific and Technical Press, Shanghai, 1999. pp. 341-342.
19. Rossini, A.A., Like, A.A., Chick, W.L., Appel, M.C., Cahill, G.F. Studies of streptozotocin-induced insulitis and diabetes. PNAS 1977; 74, 2485-2489.
20. Slonim, A.E., Fletcher, T., Burke, V., Burr, I.M. Effect of streptozotocin on red-blood-cell-reduced glutathione: modification by glucose, nicotinamide, and epinephrine. Diabetes 1976; 25, 216-222.
21. Chen, H. Carlson, E.C., Pellet, L., Moritz, J.T., Epstein, P.N. Overexpression of Metallothionein in Pancreatic β-Cells Reduces Streptozotocin- Induced DNA Damage and Diabetes. Diabetes 2001; 50, 2040-2046.
22. Coppey, L.J., Gellett, J.S., Davidson, E.P., Dunlap, J.A., Lund, D.D., Yorek, M.A. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve. Diabetes 2001; 50, 1927-1937.
23. Kanth, V.R., Reddy P.U.M., Raju, T.N. Attenuation of streptozotocin-induced oxidative stress in hepatic and intestinal tissues of wistar rat by methanolic- garlic extract. Acta Diabetol. 2008; 45, 243-251.
24. Baynes, J.W., Thorpe, S.R. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999; 48, 1-9.
25. Antonio, C. New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy. Diabetes Care 2003; 26, 1589-1596.
26. Scott, J.A., King, G.L. Oxidative stress and antioxidant treatment in diabetes. Ann. N. Y. Acad. Sci. 2004; 1031, 204-213.
27. Niu, N., Li, Y., Wu, C.M., Wang, K., Wang, Y.L., Pan, J.M., Qin, J. Effect of ShanTangPing on blood fat in hyperlipoidemia model of rat. Journal of Sichuan Traditional Chinese Medicine 2006; 24, 21-22.